Seqens Seqens

X
[{"orgOrder":0,"company":"Sipp Industries","sponsor":"SinuSave","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"Sipp Industries Announces Distribution Agreement for Patented SinuSave\u00ae CBD Nasal Spray","therapeuticArea":"Neurology","highestDevelopmentStatus":"Approved","country":"U.S.A","productType":"Small molecule","productStatus":"Approved","date":"January 2024","url1":"","url2":"","graph1":"Neurology","graph2":"Approved"}]

Find Clinical Drug Pipeline Developments & Deals by Sipp Industries

Menu
Loading...
Filters Filter
×
FILTER:
filter Company
    filter Sponsor
      filter Country
        filter Therapeutic Area
          filter Study Phase

            Active Filter(s):

            Companies By Therapeutic Area

            Development Status

            Details:

            Under the agreement, Sipp Industries will manufacture SinuSave® CBD Nasal Spray products. SinuSave® CBD is proven to be bacteriostatic and bactericidal.

            Lead Product(s): Cannabidiol

            Therapeutic Area: Neurology Product Name: SinuSave

            Highest Development Status: Approved Product Type: Small molecule

            Partner/Sponsor/Collaborator: SinuSave

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Agreement January 23, 2024

            ASK
            US
            PHARMACOMPASS
            Upload
            your Pipeline Activity
            Post Enquiry
            POST ENQUIRY